Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of cinnarizine and betahistine in the treatment of peripheral vertigo
IRCT20171030037093N16Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cinnarizine and betahistine in Peripheral vertigo, sponsored by Shahrekord University of Medical Sciences. Started Jul 2019; status: completed.
02
Drugs
cinnarizinebetahistine
03
Conditions
Peripheral vertigo
Beyond the preview
Go deeper on IRCT20171030037093N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N16.